Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dapagliflozin (Forxiga)”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Early research (Phase 1)Study completedNCT02722239
What this trial is testing

An Open-label, Randomized, Crossover Study of Comparative Pharmacokinetics and Bioequivalence of Dapagliflozin + Metformin, 10 mg + 1000 mg Versus the Combined Use of Forxiga™, 10 mg and Two Glucophage® Long, ER Tablets, 500 mg Co-administered to Healthy Volunteers Under Standard Fed Conditions

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 40
Post-approval studies (Phase 4)Study completedNCT02616666
What this trial is testing

A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes Mellitus
University of Liverpool 632
Not applicableStudy completedNCT02252224
What this trial is testing

Forxiga (Dapagliflozin) Regulatory Postmarketing Surveillance

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 3,123
Not applicableActive Not RecruitingNCT07204743
What this trial is testing

Efficacy and Safety of Dapagliflozin in Children With Proteinuria

Who this might be right for
SGLT 2 InhibitorsPediatric Kidney DiseaseProteinuric Diseases+1 more
Al-Quds University 10
Not applicableEnded earlyNCT01944618
What this trial is testing

ForREAL: FORXIGA PRESCRIPTION EVENT MONITORING PROGRAM (PEMP)

Who this might be right for
Type 2 Diabetes
AstraZeneca 5,000
Not applicableStudy completedNCT07210307
What this trial is testing

Safety Of DAPAGLIFLOZIN (FORXIGA) in Patient With Type 2 Diabetes Mellitus (T2dm) In Vietnam From A Post-Marketing Surveillance Program

Who this might be right for
Safety Outcomes
AstraZeneca 1,001
Testing effectiveness (Phase 2)Active Not RecruitingNCT06748105
What this trial is testing

Dapagliflozin as Prophylaxis for Glucocorticoid-Induced Hyperglycemia

Who this might be right for
Dapagliflozin (Forxiga)HyperglycaemiaGlucocorticoid
Lauro Fabián Amador Medina 38
Not applicableStudy completedNCT06127212
What this trial is testing

Bioequivalence Study of Dapagliflozin 10 mg Film-coated Tablets

Who this might be right for
Healthy
Dexa Medica Group 24
Early research (Phase 1)UnknownNCT06233045
What this trial is testing

Dapagliflozin Tablet 10 mg Relative to Forxiga® Tablets 10 mg

Who this might be right for
Healthy Subjects
Bio-innova Co., Ltd 30
Early research (Phase 1)Study completedNCT01877889
What this trial is testing

Compare the Pharmacodynamics of Canagliflozin and Dapagliflozin in Healthy Volunteers

Who this might be right for
Healthy
Janssen-Cilag International NV 60
Early research (Phase 1)Study completedNCT04856007
What this trial is testing

Assess the Bioequivalence of Fixed Dose Combination of Dapagliflozin/Metformin XR Relative to Co-administration of the Individual Components in Healthy Chinese Subjects.

Who this might be right for
Healthy Volunteer
AstraZeneca 80
Large-scale testing (Phase 3)Study completedNCT02113241
What this trial is testing

Effect of Dapagliflozin Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion

Who this might be right for
Metabolic Syndrome X
University of Guadalajara 24
Testing effectiveness (Phase 2)Looking for participantsNCT06845163
What this trial is testing

Randomized Clinical Trial to Evaluate the Effect of Dapagliflozin in Patients With Diabetic Macular Edema

Who this might be right for
Diabetic Macular EdemaCenter-involved Diabetic Macular Edema
Alexandria University 56
Post-approval studies (Phase 4)Looking for participantsNCT06668389
What this trial is testing

Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial

Who this might be right for
Congenital Heart DiseaseRepaired Tetralogy of Fallot (rTOF)Pulmonary Regurgitation+2 more
The University of Hong Kong 106
Early research (Phase 1)Not Yet RecruitingNCT06759909
What this trial is testing

Dapagliflozin on Outcomes of Rhythm Control Strategy (Pharmacological ± Interventional) in Patient with Atrial Fibrillation

Who this might be right for
Dapagliflozin (Forxiga)Atrial Fibrillation (AF)
Assiut University 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT06750458
What this trial is testing

Dapagliflozin Versus Dexamethasone Role in Pre-operative Management of Non- Diabetic Brain Tumor Patients

Who this might be right for
GliomaDapagliflozin (Forxiga)Dexamethasone
Tanta University 75